Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Our take

Invyncible is worth comparing for readers who prefer to request each refill. Its listed amount becomes a meaningful budget only after the prescription duration and pharmacy costs are confirmed.

$179.10 listed; treatment duration variesSupply duration is not published as a monthly rate
InjectionFormat offered
Prescription requiredSubject to clinical evaluation

What stands out

  • Refills are not automatic
  • Pharmacy network and choice explained
  • Outcome limitations clearly acknowledged

What to weigh

  • No fixed supply duration beside price
  • Unavailable in California and Oregon
  • Supplies and formulation vary by pharmacy

A priced program without a monthly promise

Invyncible lists its sermorelin program as 9 mg, with $179.10 shown beside a $199 reference price. The page does not attach a fixed treatment duration to that amount. It would therefore be misleading to call this a $179.10 monthly subscription or compare it directly with a competitor’s thirty-day package.

Ask how much medication the selected prescription provides, how long that supply is intended to last and whether the displayed discount applies to another order. Those answers should come from the actual prescription and quote. A product title can help identify a listing, but it is not a substitute for the concentration, quantity and directions on a pharmacy label.

Manual refills change the experience

The FAQ says refills are not automatic and advises placing a request at least a week before the current treatment runs out. That is a meaningful difference for someone who dislikes recurring charges. It also means the patient needs to track the remaining supply and allow time for the next review.

My preference would be to set a reminder based on the pharmacy’s instructions rather than a generic calendar month. Ask whether a refill needs updated information and how to request a review if your circumstances change. An order history is useful, but repeating a past purchase should not become a reason to skip a clinical question about whether the same treatment is still appropriate.

Pharmacy choice comes with a separate comparison

Invyncible publishes a network including Empower, Strive, Center City, Partell, PerfectRx and MFV. It also allows patients to indicate another pharmacy or request a prescription copy, subject to the pharmacy’s ability to fill it. The site cautions that pricing, availability and shipping can change outside its network.

This is useful flexibility if you already work with a compounding pharmacy. Request the full cost for that arrangement before assuming the storefront figure travels with the prescription. Compare the prescribed preparation, dispensing quantity, delivery conditions and support contacts together. A network list shows possible partners, not a promise that every listed pharmacy dispenses every formulation in every state. Confirm which pharmacy will handle your specific order.

The claims are unusually restrained

The sermorelin page explicitly separates the medication’s biological mechanism from proof of outcomes. It says the compounded treatment has not been established as an anti-aging therapy or proven to deliver a range of advertised wellness benefits. It also says prescribing is individualized and identifies California and Oregon as unavailable for this product.

That restraint is a reason to take the disclosures seriously, not evidence that this particular service produces better clinical results. Use the consultation to identify the concern being evaluated and the basis for any recommendation. An honest discussion should also establish what information would lead the clinician to reassess the plan. Progress should not be judged solely against promotional before-and-after expectations found elsewhere.

Understand approval and processing

The FAQ describes a payment authorization at checkout, with payment finalized only after physician approval. It says patients should allow up to five to seven business days for review and pharmacy processing before shipment. Overnight transit, where selected, does not remove those earlier stages.

Plan around the whole process if timing matters. A pending bank entry can affect available funds even when approval has not happened, and the bank controls how quickly a released authorization disappears. Keep the order confirmation and ask support which stage applies if there is a delay. Before changing an address or abandoning an order, request confirmation that the pharmacy has received the change; a message sent after processing may arrive too late.

A good fit for deliberate reordering

Invyncible deserves consideration for its manual refill model and published pharmacy choices. Its tradeoff is the extra work needed to translate a program price into a personal treatment budget. Readers who want an immediately comparable monthly bill will need more information before deciding whether it is affordable.

Ask for a single written summary of the formulation, expected supply, total cost, pharmacy and next review point. Include any recommended testing and whether administration supplies are provided. This review reflects public pages checked in October 2026 and no firsthand care experience. Our online prescription guide offers context for those questions. The program’s availability and careful wording should not be mistaken for evidence that treatment is suitable for everyone who can order an evaluation.

Common questions

Is Invyncible $179.10 per month?

No monthly duration is established beside the 9 mg listing. Ask how long the prescribed supply should last.

Does Invyncible automatically refill?

Its FAQ says refills are not automatic and recommends requesting the next supply at least one week before running out.

Can I choose a pharmacy?

The pharmacy page permits pharmacy choice or a prescription copy, subject to fulfillment requirements. Outside-network prices and timing can differ.

Explore Invyncible

See the current offer and decide whether you want to start a consultation.

Visit Invyncible

Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Sources & further reading

Provider prices and terms may change.

  1. Invyncible website
  2. FDA: Understanding the risks of compounded drugs
  3. Endocrine Society: Hormones and Aging scientific statement